Literature DB >> 20719224

Quality assessment for human papillomavirus testing.

Sepehr N Tabrizi1.   

Abstract

There are over 30 commercial, as well as numerous in-house assays, available for human papillomavirus testing. Laboratories performing such assays would need to assess accuracy and reproducibility of their results by incorporating ongoing internal control as well as participating in external quality-assurance schemes (EQAS) as part of their quality assurance program. Several EQAS are available and participation in which is a requirement for laboratories engaged in HPV testing. It is important that laboratories select the appropriate panels for detection of targeted types covered by assay used. Failure to do so can possibly alter patient management and increase the cost of treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719224     DOI: 10.1071/SH09152

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  1 in total

1.  Comparison of PapType to Digene Hybrid Capture 2, Roche linear array, and Amplicor for detection of high-risk human papillomavirus genotypes in women with previous abnormal pap smears.

Authors:  Sepehr N Tabrizi; Matthew P Stevens; Zaheer A Khan; Conan Chow; Martin A Devitt; Suzanne M Garland
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.